Abstract:Background Motor neuron degeneration or loss in the spinal cord is the characteristic phenotype of motor neuron diseases or spinal cord injuries. Being proliferative and located near neurons, astrocytes are considered ideal cell sources for regenerating neurons. Methods We selected and tested different combinations of the small molecules for inducing the conversion of human and mouse astrocytes into neurons. Microscopic imaging and immunocytochemistry analyses were used to characterize the morphology and phenotype of the induced neurons while RT-qPCR was utilized to analyze changes in gene expression. In addition, whole-cell patch-clamp recordings were measured to examine the electrophysiological properties of induced neurons. Results The results showed that human astrocytes could be rapidly and efficiently converted into motor neuron-like cells by treatment with defined small molecules, with a yield of over 85% motor neuron-like cells attained. The induced motor neuron-like cells expressed the pan-neuronal markers TUJ1, MAP2, NeuN, and Synapsin 1 and motor neuron markers HB9, ISL1, CHAT, and VAChT. During the conversion process, the cells did not pass through a proliferative neural progenitor cell intermediate. The induced motor neurons were functional, showing the electrophysiological properties of neurons. The same chemical cocktail could induce spinal cord astrocytes from an amyotrophic lateral sclerosis mouse model carrying a SOD1 mutation to become motor neuron-like cells that exhibited a decrease in cell survival and an increase in oxidative stress compared to that observed in wild-type MNs derived from healthy mice. Moreover, the chemical induction reduced oxidative stress in the mutant astrocytes. Conclusion The results of the present study demonstrated the feasibility of chemically converting human and mouse astrocytes into motor neuron-like cells that are useful for neurodegenerative disease modeling and regenerative medicine.

Chemical Conversion of Human and Mouse Fibroblasts into Motor Neurons

Chemical Conversion of Mouse Fibroblasts into Functional Dopaminergic Neurons

Efficient and Rapid Conversion of Human Astrocytes and ALS Mouse Model Spinal Cord Astrocytes into Motor Neuron-Like Cells by Defined Small Molecules

Direct Generation of Human Neuronal Cells from Adult Astrocytes by Small Molecules.

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Direct Conversion of Normal and Alzheimer’s Disease Human Fibroblasts into Neuronal Cells by Small Molecules

Chemical Conversion of Human Lung Fibroblasts into Neuronal Cells

Small Molecular Compounds Efficiently Convert Human Fibroblasts Directly into Neurons

Sequentially induced motor neurons from human fibroblasts facilitate locomotor recovery in a rodent spinal cord injury model

Direct Conversion of Mouse Fibroblasts to Gabaergic Neurons with Combined Medium Without the Introduction of Transcription Factors or Mirnas

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Conversion of Human Fibroblasts into Induced Neural Stem Cells by Small Molecules

Direct conversion of urine-derived cells into functional motor neuron-like cells by defined transcription factors

Reprogramming of Fibroblasts to Neural Stem Cells by a Chemical Cocktail.

Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules

Attenuation of PRRX2 and HEY2 Enables Efficient Conversion of Adult Human Skin Fibroblasts to Neurons.

How to Reprogram Human Fibroblasts to Neurons